Pathology and Biorepository Core
病理学和生物样本库核心
基本信息
- 批准号:8588575
- 负责人:
- 金额:$ 15.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-09-01 至
- 项目状态:未结题
- 来源:
- 关键词:AnimalsBiological MarkersBiologyBlood specimenBrain NeoplasmsCancer CenterCaringCell Culture TechniquesCellsCentral Nervous System NeoplasmsClinicalCollaborationsDNADataDatabasesDoctor of MedicineEvaluationExperimental NeoplasmsFoundationsGliomaHistologicInstructionInvestigationMalignant neoplasm of brainNervous system structureNormal tissue morphologyPathologicPathologyPatientsProcessProteinsRNAResearchResearch PersonnelResourcesSamplingServicesSpecimenStem cellsTissue MicroarrayTissue SampleTissuesTranslational ResearchTumor TissueUniversity of Texas M D Anderson Cancer Centerbiobankdesign and constructionhuman tissueimprovedmeetingsprogramsprospectiverepositorytissue resourcetreatment effecttumor
项目摘要
A fundamental component of the translational research of the The University of Texas MD Anderson
Cancer Center Brain Cancer SPORE is conduct of focused translational research involving human tissue
and blood specimens, allowing investigation of the biology of target and normal tissues, and evaluation of
treatment effects on both target and normal tissue and on modulation of specific, relevant biomarkers. The
Pathology and Biorepository Core collects, processes and maintains human tissue specimens from
patients and will disperse these tissues and tissue-derived primary glioma stem cell (GSC) to SPORE
investigators. It has been an effective resource for the existing SPORE projects, which are heavily tissue-
dependent and will continue to serve this function in the proposed SPORE Projects going forward.
The specific objectives of the Pathology and Biorepository Core are these:
Objective 1 Maintain and enhance a repository of tumor tissue and matched blood specimens from
patients with central.nervous system (CNS) tumors receiving care at MD Anderson Cancer Center
Objective 2 Provide comprehensive histologic characterization of tissue samples used in SPORE
projects, including specimens from patients and experimental tumors in animals; expeditiously distribute
tissue specimens to SPORE investigators for analysis and provide expertise in the interpretation of studies
performed on tissue sections within SPORE projects
Objective 3 Offer centralized services, including immunohistochemical characterization of biomarkers,
tissue array design and construction and primary GSC culture of tumor samples where appropriate.
Objective 4 Support a comprehensive, prospective interactive database with detailed clinical and
pathologic data for patients with CNS tumors receiving care or evaluation at MD Anderson Cancer Center
Objective 5 Facilitate inter-SPORE collaborations through sharing of tissue resources
RELEVANCE (See instructions): DO NOT EXCEED THE SPACE PROVIDED.
Research into brain cancer depends on the availability of tumor samples obtained from patients. These
samples and the DNA, RNA, proteins, and cells derived from them (e.g. GSCs) are the foundation of any
translational program. This Core provides the patient samples that are key to understanding and curing
brain tumors.
德州大学安德森分校翻译研究的一个基本组成部分
癌症中心脑癌孢子是涉及人体组织的有针对性的翻译研究
和血液样本,允许调查目标组织和正常组织的生物学,并评估
治疗对靶组织和正常组织都有影响,对特定的相关生物标志物的调节也有影响。这个
病理学和生物库核心收集、处理和维护来自
并将这些组织和组织来源的原代胶质瘤干细胞(GSC)分散到孢子中
调查人员。它是现有孢子项目的有效资源,这些项目含有大量的组织-
在未来,它将继续在拟议的孢子项目中发挥这一作用。
病理学和生物库核心的具体目标如下:
目标1维护和增强肿瘤组织和匹配血液样本的存储库
中枢神经系统(CNS)肿瘤患者在MD Anderson癌症中心接受治疗
目的2提供用于孢子培养的组织标本的综合组织学特征
项目,包括病人标本和动物实验性肿瘤;迅速分发
将组织标本交给孢子调查员进行分析,并提供研究解释方面的专业知识
在孢子项目内的组织切片上执行
目标3提供集中服务,包括生物标记物的免疫组织化学表征,
组织阵列的设计和构建以及肿瘤样本的原代GSC培养。
目标4支持一个全面的、前瞻性的交互数据库,其中包含详细的临床和
在MD Anderson癌症中心接受护理或评估的中枢神经系统肿瘤患者的病理数据
目标5通过共享组织资源促进孢子间的合作
相关性(参见说明):不要超过所提供的空间。
对脑癌的研究取决于从患者身上获得的肿瘤样本的可用性。这些
样本及其DNA、RNA、蛋白质和源自它们的细胞(例如GSCs)是任何
翻译计划。此核心提供患者样本,这些样本是了解和治疗的关键
脑瘤。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KENNETH D ALDAPE其他文献
KENNETH D ALDAPE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KENNETH D ALDAPE', 18)}}的其他基金
TOWARDS A REFINED MOLECULAR RECURSIVE PARTITIONING ANALYSIS MODEL FOR GLIOBLASTOM
建立精细的胶质母细胞分子递归分区分析模型
- 批准号:
7944134 - 财政年份:2009
- 资助金额:
$ 15.15万 - 项目类别:
TOWARDS A REFINED MOLECULAR RECURSIVE PARTITIONING ANALYSIS MODEL FOR GLIOBLASTOM
建立精细的胶质母细胞分子递归分区分析模型
- 批准号:
7853814 - 财政年份:2009
- 资助金额:
$ 15.15万 - 项目类别:
Predictive Markers to Personalize Medicine for Malignant Glioma
恶性胶质瘤个性化医疗的预测标记
- 批准号:
8588569 - 财政年份:2008
- 资助金额:
$ 15.15万 - 项目类别:
Predictive Markers to Personalize Medicine for Malignant Glioma
恶性胶质瘤个性化医疗的预测标记
- 批准号:
8753978 - 财政年份:2008
- 资助金额:
$ 15.15万 - 项目类别:
Predictive Markers to Personalize Medicine for Malignant Glioma
恶性胶质瘤个性化医疗的预测标记
- 批准号:
8918452 - 财政年份:2008
- 资助金额:
$ 15.15万 - 项目类别:
Prediction of Chemoradiation response in Glioblastoma to individualize Therapy
预测胶质母细胞瘤的放化疗反应以进行个体化治疗
- 批准号:
7450205 - 财政年份:2008
- 资助金额:
$ 15.15万 - 项目类别:
Predictive Markers to Personalize Medicine for Malignant Glioma
恶性胶质瘤个性化医疗的预测标记
- 批准号:
9128424 - 财政年份:2008
- 资助金额:
$ 15.15万 - 项目类别:
相似海外基金
MRI and Biological Markers of Acute E-Cigarette Exposure in Smokers and Vapers
吸烟者和电子烟使用者急性电子烟暴露的 MRI 和生物标志物
- 批准号:
10490338 - 财政年份:2021
- 资助金额:
$ 15.15万 - 项目类别:
MRI and Biological Markers of Acute E-Cigarette Exposure in Smokers and Vapers
吸烟者和电子烟使用者急性电子烟暴露的 MRI 和生物标志物
- 批准号:
10353104 - 财政年份:2021
- 资助金额:
$ 15.15万 - 项目类别:
Investigating pollution dynamics of swimming pool waters by means of chemical and biological markers
利用化学和生物标记物研究游泳池水体的污染动态
- 批准号:
21K04320 - 财政年份:2021
- 资助金额:
$ 15.15万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
MRI and Biological Markers of Acute E-Cigarette Exposure in Smokers and Vapers
吸烟者和电子烟使用者急性电子烟暴露的 MRI 和生物标志物
- 批准号:
10688286 - 财政年份:2021
- 资助金额:
$ 15.15万 - 项目类别:
Novel biological markers for immunotherapy and comprehensive genetic analysis in thymic carcinoma
用于胸腺癌免疫治疗和综合遗传分析的新型生物标志物
- 批准号:
20K17755 - 财政年份:2020
- 资助金额:
$ 15.15万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Examination of Biological Markers Associated with Neurobehavioral and Neuropsychological Outcomes in Military Veterans with a History of Traumatic Brain Injury
与有脑外伤史的退伍军人的神经行为和神经心理结果相关的生物标志物的检查
- 批准号:
10578649 - 财政年份:2019
- 资助金额:
$ 15.15万 - 项目类别:
Examination of Biological Markers Associated with Neurobehavioral and Neuropsychological Outcomes in Military Veterans with a History of Traumatic Brain Injury
与有脑外伤史的退伍军人的神经行为和神经心理结果相关的生物标志物的检查
- 批准号:
10295141 - 财政年份:2019
- 资助金额:
$ 15.15万 - 项目类别:
Examination of Biological Markers Associated with Neurobehavioral and Neuropsychological Outcomes in Military Veterans with a History of Traumatic Brain Injury
与有脑外伤史的退伍军人的神经行为和神经心理结果相关的生物标志物的检查
- 批准号:
10041708 - 财政年份:2019
- 资助金额:
$ 15.15万 - 项目类别:
Examination of Biological Markers Associated with Neurobehavioral and Neuropsychological Outcomes in Military Veterans with a History of Traumatic Brain Injury
与有脑外伤史的退伍军人的神经行为和神经心理结果相关的生物标志物的检查
- 批准号:
9776149 - 财政年份:2019
- 资助金额:
$ 15.15万 - 项目类别:
Combining biological and non-biological markers to develop a model predictive of treatment response for individuals with depression
结合生物和非生物标志物来开发预测抑郁症患者治疗反应的模型
- 批准号:
2063934 - 财政年份:2018
- 资助金额:
$ 15.15万 - 项目类别:
Studentship














{{item.name}}会员




